Tamoxifen and the uterus and endometrium

Cano A, A Cano, Matallin P, P Matallin, Legua V, V. Legua, M Tortajada, Tortajada M, Bonilla-Musoles F, F Bonilla-Musoles
Lancet (London, England) · 1989 · PMID:18446930
case-report public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-08-23 ⓘ

The provided text contains only the title "Tamoxifen and the uterus and endometrium" without an abstract, making it impossible to summarize the specific findings or study details.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Estrogen Antagonists Ovarian Neoplasms Tamoxifen Adult Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Breast Neoplasms Breast Neoplasms Endometriosis Endometriosis Endometrium Endometrium Estrogen Antagonists Estrogen Antagonists Female Humans Ovarian Neoplasms Tamoxifen Tamoxifen

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-27T09:11:36.575535+00:00
pubmed
last seen: 2026-05-13T22:09:15.954262+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine